Who
Guy Archibald Innes
Director
Company insider
Files Form 4 as: Director, VolitionRX.
In numbers
- Trades disclosed
- 129
- Buys
- 22
- Sells
- 0
- Bought
- $44.5B
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 25 Mar 2013
- Last trade
- 26 Feb 2026
- Last filed
- 27 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Feb 2026filed 27 Feb 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —178,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —178,000 at $0.00 | filing |
| 22 Jan 2026filed 23 Jan 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 22 Jan 2026filed 23 Jan 2026 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 14 Oct 2025filed 15 Oct 2025 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code P | $96296,153 at $0.01 | filing |
| 14 Oct 2025filed 15 Oct 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $49K96,153 at $0.51 | filing |
| 5 Aug 2025filed 6 Aug 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $50K78,125 at $0.64 | filing |
| 3 Jun 2025filed 4 Jun 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $11K20,000 at $0.54 | filing |
| 26 Mar 2025filed 27 Mar 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $100K181,818 at $0.55 | filing |
| 1 Mar 2025filed 4 Mar 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —19,786 at $0.00 | filing |
| 29 Jan 2025filed 31 Jan 2025 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —25,000 | filing |
| 29 Jan 2025filed 31 Jan 2025 | VNRX VolitionRXoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —25,000 | filing |
| 15 Jan 2025filed 17 Jan 2025 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 9 Dec 2024filed 10 Dec 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $100K174,764 at $0.57 | filing |
| 1 Dec 2024filed 3 Dec 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —17,296 at $0.00 | filing |
| 1 Sep 2024filed 4 Sep 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —18,342 at $0.00 | filing |
| 20 Aug 2024filed 21 Aug 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Bought | $101K150,000 at $0.67 | filing |
| 15 Aug 2024filed 16 Aug 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 4 Jul 2024filed 5 Jul 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code G | —400,000 at $0.00 | filing |
| 4 Jul 2024filed 5 Jul 2024 | VNRX VolitionRXDiagnostics & Labs | SEC FORM 4 Code G | —400,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.